Section 144 in Mangaluru from 8pm on Aug 4 to 6am on Aug 6

Bengaluru, Mar 18: In the backdrop of the breakdown of the COVID-19 virus across the state, the ongoing Budget session of the Karnataka Assembly, which is scheduled to end of this month, is likely to be cut short by one week.

According to official sources, the state government, which had shut down all the congregating places including Malls, Theatres, Marriage Halls and banned all the public functions, is in favor of the cutting short the ongoing Assembly session, to give focus on keeping a tab on the COVID-19 disease.

Bengaluru, May 8: Karnataka Chief Minister BS Yediyurappa on Friday held a meeting with opposition parties at his office here over COVID-19 situation in the state.

Former Chief Minister Siddaramaiah, Congress leaders SR Patil and DK Shivakumar participated in the meeting. From Janata Dal (Secular), former Chief Minister HD Kumaraswamy and HD Revanna were present.

"Congress legislative party leader Siddaramaiah and DK Shivkumar have arranged the Chief Minister to request the central government to announce a special package of Rs 50,000 crore to Karnataka to fight coronavirus and also special packages requested for small and medium scale industries," said Siddaramaiah's media secretary.

Meanwhile, Yediyurappa has announced a special package for those involved in leather works, especially those who work on the roadside.

The special package has been announced for cobblers and leather workers, who work on the roadside.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.